Navigation Links
DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
Date:10/7/2010

AUSTIN, Texas, Oct. 7 /PRNewswire/ -- DiFUSION Technologies is a medical device company focused on the development and commercialization of its proprietary CleanFUZE™ antimicrobial technology for orthopedic implants and its new Xiphos™ line of Posterior Interbody products for spinal surgery.

"Post-operative infections are a major problem today, and with the further proliferation of drug resistant bacteria, preventing the infections is even more important than it has been in the past.  Having materials that actively fight against post-operative infections is an important step towards eliminating this devastating problem," said Dr. Nitin N. Bhatia, MD, Chief, Spine Service Co-Director, Combined Spine Program, Residency Program Director Dept. of Orthopedic Surgery, University of California, Irvine.

DiFUSION's recently completed third party animal tests showed that after introducing Methicillin Resistant Staphylococcus Aureus (MRSA), a common, aggressive, multi-drug resistant bacterium, to rabbits implanted with DiFUSION's proprietary CleanFUZE orthobiologic polymer, the animals showed little visible inflammation or infection. Microscopic analysis of the same samples showed CleanFUZE to be up to 99.99% effective in eradicating the active infection.

"This is the first time any potential biomaterial has shown, in an animal model, to significantly reduce the numbers of an infectious agent as well as the local tissue markers of actual infection," said Matthew Geck, MD, cofounder of DiFUSION. "This was done using a safe and tissue friendly, pharmacologic dosing of silver with our innovative and proprietary biomaterial that combines the structural properties of PEEK with the controlled elution of cationic silver. This biomaterial has the potential to be the base material for a whole range of spine and orthopedic implants."

According to a variety of large published studies, post-operative surgical site infections (SSIs) occur in
'/>"/>

SOURCE DiFUSION Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. DiFUSION Technologies Adds Accomplished Senior Management Team
2. DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion
3. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
4. medSage Technologies Introduces Revolutionary Universal CPAP Monitor
5. All-Time High in Q Orders for Wound Management Technologies, Inc.
6. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
7. Thompson Group Acquires Hamilton Sundstrands Applied Instrument Technologies
8. Objet Geometries and Javelin Technologies Form Strategic Distribution Partnership for 3D Printers
9. Delta Health Technologies ClinicalVirtuoso™ Targets Homecare Therapists
10. Medisafe 1 Technologies Successfully Tests Prototype of Patented Syringe Locking Device
11. Palatin Technologies to Present at 9th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...
(Date:5/23/2013)... Engeland, May 23, 2013 Nederland ... met lagere urinewegsymptomen geassocieerd met BPH Astellas ... dochteronderneming van Astellas Pharma Inc, gebaseerd in ... kondigde vandaag aan dat het Nederlandse College ter Beoordeling ... in Nederland. De handelsvergunning verleend voor VESOMNI ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4
(Date:5/23/2013)... May 23, 2013 A medical malpractice ... Court (reference number 110504/2009) by Lori Mandel, an office ... Ms. Mandel $8.6 million. Ms. Mandel sought the medical ... led to further complications that affected the quality of ... , The plaintiff alleged that her doctor rendered conservative ...
(Date:5/23/2013)... May 23 2013 - New techniques in imaging ... from McGill University,s Montreal Neurological Institute, and his ... from epilepsy. The combination of electroencephalogram (EEG) ... more precise localization of the areas generating epileptic ... optimal ways of intervention, if appropriate. These ...
(Date:5/23/2013)... 2013 According to a new market ... Management; Subscriber Data Management (SDM); Telecom Application Server; Service ... (2013 – 2018)", published by MarketsandMarkets, the SDP Market ... a CAGR of 9.15% from 2013 to 2018. , ... , 84 Figures , 189 ...
(Date:5/23/2013)... Miami, FL (PRWEB) May 23, 2013 In ... in 7 years. This doesn’t mean, however, that Florida’s good ... National Hurricane Center . This year, he encourages residents, it ... During hurricane season 2013, forecasters are predicting there to be ... reports WUFT . With hurricane season lasting from June ...
(Date:5/23/2013)... Worldwide Power Products (WPP), a power-generation ... has licensed the rights to sell Hythane Company's ... burn a mixture of natural gas and diesel. WPP ... for sale and rental and will also sell ... WPP's service technicians will be certified to install the ...
Breaking Medicine News(10 mins):Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2Health News:Worldwide Power Products Announces Partnership with Hythane Company to Offer OptiBlend™ Bi-Fuel Solution for Diesel Engines 2Health News:Worldwide Power Products Announces Partnership with Hythane Company to Offer OptiBlend™ Bi-Fuel Solution for Diesel Engines 3
... The Health Minister Iris Evans says that Albertans are hoping for ... ,On the other hand the Albertans are known ... has prepared the initial phase of the new health care plan ... also plans to introduce more reforms by the end of the ...
... be used for regeneration of broken bones in a new ... headed by York University and // researchers from UK and ... biology, sociology and Philosophy from York University is aimed at ... the treatment of bone defects and fractures. ,Professor ...
... India as eliminated Leprosy but still we have to eradicate ... increasing the awareness regarding the // transmission of the bacteria ... disease. ,Indian Health Minister Dr. Anbumani Ramadoss during ... completely eradicate the disease which as about a 1 Lakh ...
... Doctors in New South Wales are angry at a proposal to ... Carroll, spokesman for the medical staff council at Wagga // Base ... elective surgery every fourth Friday. ,"So it'd create a ... relatively small amount of money but at great cost to patient ...
... University of Texas has revealed that moderate physical activity ... in easing depression. // Other measures adopted by ... smoking are associated with adverse health effects. ... 40 individuals, diagnosed with depression. None of the study ...
... study conducted on the prevalence of diabetes in the Indian ... has been uncovered. // So far, such studies have ... cannot be applied to South Asians. ,The research ... Diabetes Research Centre, an association of the World Health Organization ...
Cached Medicine News:Health News:Prevention And Control Of Diabetes Crucial To Indian Population 2
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce large devices for vascular intervention....
Medicine Products: